LONG BEACH, Calif. -- Prefilled syringes to treat macular degeneration caused larger and more frequent spikes in intraocular pressure (IOP) as compared with medication drawn from vials, a study of ...
Credit: Takeda. The approval was based on data from the phase 3 VISIBLE 2 trial. Results showed 48% of patients treated with vedolizumab SC were in clinical remission at week 52 compared with 34% of ...
Prefilled Syringes Market Prefilled Syringes Market Growth Rate By Region · GlobeNewswire Inc. Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Prefilled Syringes - Market Share Analysis, Industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results